Advances in bowel endometriosis: epidemiology, pathogenesis, diagnosis, treatment, and future perspectives

In: Reproductive Biology and Endocrinology · 2026 · doi:10.1186/s12958-026-01623-z · W7222951991
Review OA: gold CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-23 ⓘ

This narrative review summarizes recent advances in bowel endometriosis, covering its epidemiology, multifactorial pathogenesis, diagnostic imaging strategies, individualized treatment options, and multidisciplinary management approaches.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-23 · read from full text ⓘ

This narrative review examines bowel endometriosis, defined as the infiltration of endometrial glands and stroma into the bowel wall, which predominantly affects the rectosigmoid colon. The authors detail multifactorial pathogenesis including retrograde menstruation and immune dysregulation, while evaluating multimodal imaging strategies like MRI and endoscopic ultrasonography for accurate diagnosis. Treatment approaches range from hormonal therapy to various surgical resections, with a strong emphasis on multidisciplinary team management and the significant burden caused by delayed diagnosis. This paper is centrally about endometriosis — specifically the epidemiology, pathogenesis, and clinical management of deep infiltrating lesions within the bowel.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Bowel endometriosis (BE), the most common extra-pelvic manifestation of endometriosis and one of the most challenging subtypes of deep infiltrating endometriosis (DIE), is defined by endometrial glands and stroma infiltrating the bowel wall with involvement of the muscularis propria. Rectosigmoid involvement accounts for approximately 90% of all intestinal lesions. BE causes progressive pelvic pain, severe gastrointestinal dysfunction, and subfertility, substantially impairing the physical and psychological well-being of women of reproductive age. This narrative review comprehensively summarizes recent advances in the epidemiology, multifactorial pathogenesis (retrograde menstruation, coelomic metaplasia, immune dysregulation, neuroinvasion, gut microbiota, and somatic driver mutations), clinical presentation and quality-of-life impact, multimodal imaging strategies (International Deep Endometriosis Analysis [IDEA], enhanced ultrasonography, magnetic resonance imaging [MRI], endoscopic ultrasonography), individualized treatment (hormonal therapy, shaving, discoid resection, segmental resection), and multidisciplinary team (MDT) management of BE. We additionally discuss classification/staging systems (the ENZIAN score), surgical decision-making algorithms including ultrasound-guided classification (UBESS) and degree of muscular infiltration, complementary and nutritional therapies, fertility preservation, long-term prognosis and recurrence (including persistent symptoms despite surgery), and future precision-medicine directions, accompanied by a graded appraisal of the quality of available evidence. A particular focus is placed on delayed diagnosis, which remains a major contributor to disease burden.
Full text 3,281 characters · extracted from oa-html · click to expand
Abstract Bowel endometriosis (BE), the most common extra-pelvic manifestation of endometriosis and one of the most challenging subtypes of deep infiltrating endometriosis (DIE), is defined by endometrial glands and stroma infiltrating the bowel wall with involvement of the muscularis propria. Rectosigmoid involvement accounts for approximately 90% of all intestinal lesions. BE causes progressive pelvic pain, severe gastrointestinal dysfunction, and subfertility, substantially impairing the physical and psychological well-being of women of reproductive age. This narrative review comprehensively summarizes recent advances in the epidemiology, multifactorial pathogenesis (retrograde menstruation, coelomic metaplasia, immune dysregulation, neuroinvasion, gut microbiota, and somatic driver mutations), clinical presentation and quality-of-life impact, multimodal imaging strategies (International Deep Endometriosis Analysis [IDEA], enhanced ultrasonography, magnetic resonance imaging [MRI], endoscopic ultrasonography), individualized treatment (hormonal therapy, shaving, discoid resection, segmental resection), and multidisciplinary team (MDT) management of BE. We additionally discuss classification/staging systems (the ENZIAN score), surgical decision-making algorithms including ultrasound-guided classification (UBESS) and degree of muscular infiltration, complementary and nutritional therapies, fertility preservation, long-term prognosis and recurrence (including persistent symptoms despite surgery), and future precision-medicine directions, accompanied by a graded appraisal of the quality of available evidence. A particular focus is placed on delayed diagnosis, which remains a major contributor to disease burden. Similar content being viewed by others Author information Authors and Affiliations Corresponding author Ethics declarations Competing interests The authors declare no competing interests. Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. About this article Cite this article Ye, Q., Li, Y. & Li, X. Advances in bowel endometriosis: epidemiology, pathogenesis, diagnosis, treatment, and future perspectives. Reprod Biol Endocrinol (2026). https://doi.org/10.1186/s12958-026-01623-z Received: Accepted: Published: DOI: https://doi.org/10.1186/s12958-026-01623-z

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-11-03T06:04:16.201798+00:00
License: CC0 · commercial use OK